Clinical trial · Observational
Survey of Testosterone Levels in Male Cancer Patients
Survey of Testosterone Levels in a Diverse Set of Male Patients With Hormone-Independent Cancers
NCT00483418CI-TRIAL-00004558completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to survey the total serum testosterone levels in male patients with hormone-independent malignancies. The prevalence of hypogonadism is not known, but is thought to be significant. Results will be adjusted for age and stratified for type of cancer, stage, study site,and presence of opiate use for pain management, which is known to reduce testosterone levels.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hypogonadism | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18 or older * Male Cancer patients coming to oncology appointments for treatment or follow-up * Must be able to answer questionnaire in english, alone or with assistance * Informed consent Exclusion Criteria: * Known HIV infection * Known hypogonadism * testosterone or DHEA supplementation within 3 months * prostate, breast, or testicular cancer
References
Publications (0)
Data not yet available
No reference posted for this study.